Please login to the form below

Not currently logged in
Email:
Password:

animal health

This page shows the latest animal health news and features for those working in and with pharma, biotech and healthcare.

GSK: we won’t be splitting up any time soon

GSK: we won’ t be splitting up any time soon. Walmsley scotches rumours of a consumer health spin-off. ... The decision is in contrast to firms such as Novartis (selling its eyecare divison Alcon) and Lilly, which just announced the spin-off its animal

Latest news

More from news
Approximately 15 fully matching, plus 114 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    There were six deals worth more than $1bn this month: three focused on medtech, two on ethical pharmaceuticals and one in nutrition/ consumer health. ... animal health business (Merial) for Boehringer Ingelheim's consumer healthcare business.

  • Deal Watch October 2016 Deal Watch October 2016

    For Lilly this is a good deal as it acquired the Novartis Animal Health business for $4.5bn last year and Elanco, its animal health business, is now said to be ... one of the top three animal health companies.

  • Deal Watch May 2016 Deal Watch May 2016

    It is thought that Bayer can run to as much as $140 per share and rumours are abounding about a sale of its animal health interests to support the acquisition. ... This would be in line with the long standing advice of build up or exit for Bayer's animal

  • The human perspective The human perspective

    The latter deal will see Boehringer hand its consumer health interests to Sanofi in return for the French pharma firm's animal health arm Merial.

  • Deal Watch March 2016 Deal Watch March 2016

    In the animal health field Dechra Pharmaceuticals has expanded its presence in the US with the acquisition for $200m in cash of Putney, a developer of products for companion animals. ... Acquisition - company. $300. Putney/ Dechra. Animal health –

More from intelligence
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest appointments

  • Pfizer names Albert Bourla as COO Pfizer names Albert Bourla as COO

    He has held several positions at Pfizer including general manager of the company’s established products business unit and area president for its animal health business across the EMEA regions. ... Pfizer has also promoted John Young, current group

  • Bayer appoints head of EU liaison office Bayer appoints head of EU liaison office

    Prior to his role at the IVA, Halling was responsible for communications and public relations at the International Federation for Animal Health.

  • Dr George Gunn moves from Novartis to join Nuritas Dr George Gunn moves from Novartis to join Nuritas

    Dr Gunn joins from Novartis where he acted as head of the company's animal health division and as a member of its global executive committee from 2004 until early last ... year. Prior to this, he also served as division head for consumer health and head

  • Merck KGaA 'to promote' Stefan Oschmann to chief executive Merck KGaA 'to promote' Stefan Oschmann to chief executive

    Prior to joining MSD Oschmann worked for the International Atomic Energy Agency IAEA from 1985 to 1987 and for the German Animal Health Federation (BfT) from 1987 to 1989.

  • Merck KGaA’s Oschmann elected president of IFPMA Merck KGaA’s Oschmann elected president of IFPMA

    Oschmann has worked in life sciences for several decades, including roles early in his career at the German Animal Health Federation and the German Chemical Industry Association. ... Oschmann said he was honoured to take over the role at an important

More from appointments
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics